Vor Biopharma
Roger Evans is an accomplished professional in the field of Clinical Quality Assurance and GxP compliance, currently serving as the Senior Director at Vor Bio since November 2023. Prior to this role, Roger held various senior positions, including Senior Director of R&D Quality Assurance at uniQure and Director of Quality, Research at Sage Therapeutics. With extensive experience, Roger has also led quality assurance efforts at Ironwood Pharmaceuticals, BioBridges, LLC, Vertex Pharmaceuticals, Millennium Pharmaceuticals, EMD Serono, Inc., Regeneron Pharmaceuticals, and Wyeth Biotech. This career path has equipped Roger with a robust expertise in compliance and risk management across GCP, GLP, and GMP activities, underscoring a commitment to maintaining high standards in clinical and research quality.
This person is not in any teams
This person is not in any offices
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.